The Aflac Cancer Center gives our patients access to the latest in treatments for childhood cancer and blood disorders through our research efforts.
What does this data mean?
This graph shows the total number of patients who enrolled in a therapeutic clinical trials in 2013 by program. The Aflac Cancer Center is one of the nation’s leading childhood cancer and blood disorders centers for clinical trial enrollment.
Why is this information important?
Advancements in curing childhood cancer and blood disorders are the result of research. The Aflac Cancer Center leads and participates in hundreds of national clinical trials every year.
How does the Aflac Cancer Center help ensure we are providing high-quality care?
- All of our cancer and blood disorders doctors are researchers, too
- Every patient we treat is checked to see if they can take part in a clinical trial
- Our doctors are always looking for ways to use their research to improve care for our patients.
- We are one of the national leaders for clinical trial enrollment in Children’s Oncology Group (COG) studies.
- We have a growing research program—in 2013, we had 159 patients on therapeutic clinical trials, including 47 for Phase I and Phase II trials.
- We are home to a robust Innovative Therapy Program, giving our patients access to some of the newest treatments.